Innovative Therapies Centers of Excellence Act

This bill would require the Secretary of Veterans Affairs to designate at least five VA medical facilities as centers of excellence for innovative therapies, spread across different regions. Innovative therapies are defined as MDMA, 5-MeO-DMT, ibogaine, ketamine, psilocybin, and others the VA's Under Secretary for Health may add. They would be used to treat conditions such as anxiety, depression, PTSD, chronic pain, bipolar disorder, Parkinson's disease, and substance use disorder. Facilities would be chosen after review by a panel of experts, and the VA would report yearly to Congress on the centers' activities. The bill authorizes $30 million per year for the centers' research and education.

Full text and official record on Congress.gov

Sponsors

• Ruben Gallego Democrat sponsor
• 1 cosponsors